Table 4.
Noncardiovascular death | All‐cause death* | Cancer death | Chronic kidney disease death | Chronic weight loss‐vomiting‐diarrhea‐anorexia death | Other causes of death** | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Population remaining at risk | Affected | Population remaining at risk | Affected | Population remaining at risk | Affected | Population remaining at risk | Affected | Population remaining at risk | Affected | Population remaining at risk | Affected | ||
1 year after study entry | |||||||||||||
Full population | AH | 94.5 | 5.5 | 94.2 | 5.8 | 97.2 | 2.8 | 99.4 | 0.6 | 99.3 | 0.7 | 98.3 | 1.7 |
HCM/HOCM | 94.5 | 5.5 | 87.1 | 12.9 | 98.0 | 2.0 | 99.3 | 0.7 | 99.3 | 0.7 | 98.3 | 1.7 | |
Age quartile1 | AH | 98.4 | 1.6 | 98.4 | 1.6 | 100.0 | 0.0 | 100.0 | 0.0 | 99.6 | 0.4 | 98.8 | 1.2 |
HCM/HOCM | 97.9 | 2.1 | 92.1 | 7.9 | 99.5 | 0.5 | 99.5 | 0.5 | 100.0 | 0.0 | 98.9 | 1.1 | |
Age quartile 2 | AH | 96.1 | 3.9 | 96.1 | 3.9 | 98.7 | 1.3 | 99.4 | 0.6 | 98.7 | 1.3 | 99.4 | 0.6 |
HCM/HOCM | 95.6 | 4.4 | 87.5 | 12.5 | 98.9 | 1.1 | 99.3 | 0.7 | 98.9 | 1.1 | 99.3 | 0.7 | |
Age quartile 3 | AH | 94.0 | 6.0 | 93.5 | 6.5 | 96.4 | 3.6 | 100.0 | 0.0 | 99.4 | 0.6 | 98.2 | 1.8 |
HCM/HOCM | 96.5 | 3.5 | 89.2 | 10.8 | 98.1 | 1.9 | 100.0 | 0.0 | 99.7 | 0.3 | 99.4 | 0.6 | |
Age quartile4 | AH | 86.4 | 13.6 | 85.7 | 14.3 | 91.8 | 8.2 | 98.0 | 2.0 | 99.3 | 0.7 | 96.6 | 3.4 |
HCM/HOCM | 88.0 | 12.0 | 79.8 | 20.2 | 95.7 | 4.3 | 98.3 | 1.7 | 98.7 | 1.3 | 95.3 | 4.7 | |
2.5 years after study entry | |||||||||||||
Full population | AH | 86.6 | 13.4 | 84.1 | 15.9 | 94.0 | 6.0 | 97.9 | 2.1 | 97.8 | 2.2 | 96.8 | 3.2 |
HCM/HOCM | 89.8 | 10.2 | 74.2 | 25.8 | 96.3 | 3.7 | 98.3 | 1.7 | 98.2 | 1.8 | 97.5 | 2.5 | |
Age quartile1 | AH | 96.8 | 3.2 | 95.2 | 4.8 | 99.2 | 0.8 | 100.0 | 0.0 | 99.2 | 0.8 | 98.4 | 1.6 |
HCM/HOCM | 96.8 | 3.2 | 84.1 | 15.9 | 98.9 | 1.1 | 99.5 | 0.5 | 100.0 | 0.0 | 98.9 | 1.1 | |
Age quartile 2 | AH | 91.6 | 8.4 | 90.3 | 9.7 | 98.1 | 1.9 | 98.7 | 1.3 | 97.4 | 2.6 | 97.4 | 2.6 |
HCM/HOCM | 92.6 | 7.4 | 79.0 | 21.0 | 98.2 | 1.8 | 98.5 | 1.5 | 98.2 | 1.8 | 98.9 | 1.1 | |
Age quartile 3 | AH | 83.9 | 16.1 | 81.0 | 19.0 | 92.9 | 7.1 | 98.2 | 1.8 | 97.6 | 2.4 | 95.8 | 4.2 |
HCM/HOCM | 93.0 | 7.0 | 76.1 | 23.9 | 97.1 | 2.9 | 99.0 | 1.0 | 98.7 | 1.3 | 98.4 | 1.6 | |
Age quartile 4 | AH | 66.7 | 33.3 | 61.9 | 38.1 | 82.3 | 17.7 | 93.2 | 6.8 | 95.9 | 4.1 | 94.6 | 5.4 |
HCM/HOCM | 76.4 | 23.6 | 57.9 | 42.1 | 91.0 | 9.0 | 96.1 | 3.9 | 96.1 | 3.9 | 93.6 | 6.0 | |
5 years after study entry | |||||||||||||
Full population | AH | 76.2 | 23.8 | 70.4 | 29.6 | 89.2 | 10.8 | 95.6 | 4.4 | 96.7 | 3.3 | 95.0 | 5.0 |
HCM/HOCM | 78.8 | 21.2 | 51.7 | 48.3 | 93.0 | 7.0 | 95.1 | 4.9 | 96.6 | 3.4 | 95.4 | 4.6 | |
Age quartile1 | AH | 91.7 | 8.3 | 88.1 | 11.9 | 98.0 | 2.0 | 100.0 | 0.0 | 97.6 | 2.4 | 96.8 | 3.2 |
HCM/HOCM | 94.7 | 5.3 | 67.7 | 32.3 | 98.4 | 1.6 | 99.5 | 0.5 | 99.5 | 0.5 | 98.4 | 1.6 | |
Age quartile 2 | AH | 87.1 | 12.9 | 85.2 | 14.8 | 96.1 | 3.9 | 98.7 | 1.3 | 96.8 | 3.2 | 95.5 | 4.5 |
HCM/HOCM | 87.5 | 12.5 | 62.1 | 37.9 | 97.1 | 2.9 | 97.8 | 2.2 | 97.4 | 2.6 | 97.1 | 2.9 | |
Age quartile 3 | AH | 71.4 | 28.6 | 63.7 | 36.3 | 86.3 | 13.7 | 95.2 | 4.8 | 96.4 | 3.6 | 94.6 | 5.4 |
HCM/HOCM | 80.9 | 19.1 | 51.0 | 49.0 | 92.0 | 8.0 | 95.9 | 4.1 | 97.1 | 2.9 | 96.2 | 3.8 | |
Age quartile 4 | AH | 43.5 | 56.5 | 32.0 | 68.0 | 70.1 | 29.9 | 85.0 | 15.0 | 95.2 | 4.8 | 91.8 | 8.2 |
HCM/HOCM | 52.8 | 47.2 | 27.5 | 72.5 | 85.0 | 15.0 | 87.6 | 12.4 | 92.7 | 7.3 | 90.1 | 9.9 | |
7.5 years after study entry | |||||||||||||
Full population | AH | 70.2 | 29.8 | 62.7 | 37.3 | 86.1 | 13.9 | 93.9 | 6.1 | 95.7 | 4.3 | 94.6 | 5.4 |
HCM/HOCM | 71.9 | 28.1 | 38.4 | 61.6 | 90.8 | 9.2 | 92.8 | 7.2 | 95.2 | 4.8 | 94.7 | 5.3 | |
Age quartile1 | AH | 90.5 | 9.5 | 86.5 | 13.5 | 97.6 | 2.4 | 100.0 | 0.0 | 97.2 | 2.8 | 96.4 | 3.6 |
HCM/HOCM | 93.1 | 6.9 | 59.3 | 40.7 | 97.9 | 2.1 | 99.5 | 0.5 | 99.5 | 0.5 | 98.4 | 1.6 | |
Age quartile 2 | AH | 80.6 | 19.4 | 76.1 | 23.9 | 92.3 | 7.7 | 97.4 | 2.6 | 95.5 | 4.5 | 95.5 | 4.5 |
HCM/HOCM | 83.5 | 16.5 | 50.4 | 49.6 | 95.2 | 4.8 | 97.4 | 2.6 | 96.3 | 3.7 | 96.3 | 3.7 | |
Age quartile 3 | AH | 61.9 | 38.1 | 52.4 | 47.6 | 83.3 | 16.7 | 91.7 | 8.3 | 94.6 | 5.4 | 93.5 | 6.5 |
HCM/HOCM | 71.7 | 28.3 | 36.0 | 64.0 | 88.2 | 11.8 | 92.7 | 7.3 | 94.9 | 5.1 | 95.9 | 4.1 | |
Age quartile 4 | AH | 34.0 | 66.0 | 19.7 | 80.3 | 63.3 | 36.7 | 82.3 | 17.7 | 94.6 | 5.4 | 91.8 | 8.2 |
HCM/HOCM | 41.6 | 58.4 | 10.7 | 89.3 | 83.3 | 16.7 | 82.0 | 18.0 | 91.0 | 9.0 | 88.4 | 11.6 | |
10 years after study entry | |||||||||||||
Full population | AH | 68.6 | 31.4 | 60.8 | 39.1 | 85.5 | 14.5 | 93.4 | 6.6 | 95.6 | 4.4 | 94.3 | 5.7 |
HCM/HOCM | 70.2 | 29.8 | 35.8 | 64.1 | 89.9 | 10.1 | 92.4 | 7.6 | 95.0 | 5.0 | 94.6 | 5.4 | |
Age quartile1 | AH | 89.3 | 10.7 | 85.3 | 14.6 | 97.2 | 2.8 | 100.0 | 0.0 | 97.2 | 2.8 | 95.6 | 4.4 |
HCM/HOCM | 90.5 | 9.5 | 55.6 | 44.3 | 95.8 | 4.2 | 98.9 | 1.1 | 99.5 | 0.5 | 98.4 | 1.6 | |
Age quartile 2 | AH | 77.4 | 22.6 | 72.9 | 27.0 | 91.0 | 9.0 | 96.1 | 3.9 | 94.8 | 5.2 | 95.5 | 4.5 |
HCM/HOCM | 82.0 | 18.0 | 48.2 | 51.7 | 94.9 | 5.1 | 97.4 | 2.6 | 96.0 | 4.0 | 96.0 | 4.0 | |
Age quartile 3 | AH | 60.7 | 39.3 | 50.0 | 49.9 | 82.7 | 17.3 | 91.1 | 8.9 | 94.6 | 5.4 | 93.5 | 6.5 |
HCM/HOCM | 69.7 | 30.3 | 33.4 | 66.5 | 87.3 | 12.7 | 91.7 | 8.3 | 94.9 | 5.1 | 95.9 | 4.1 | |
Age quartile 4 | AH | 32.7 | 67.3 | 18.4 | 81.5 | 62.6 | 37.4 | 81.6 | 18.4 | 94.6 | 5.4 | 91.8 | 8.2 |
HCM/HOCM | 40.8 | 59.2 | 8.5 | 91.5 | 82.8 | 17.2 | 82.0 | 18.0 | 90.6 | 9.4 | 88.4 | 11.6 |
Note: For each cause of death listed in the top row, the percentage of affected population and remaining population still at risk is designated for each age quartile recorded at study entry. Risk is further detailed at 1‐, 2.5‐, 5‐, 7.5‐, and 10‐year intervals after study entry.
Abbreviations: AH, apparently healthy cats; HCM, nonobstructive hypertrophic cardiomyopathy; HOCM, obstructive hypertrophic cardiomyopathy.
Includes all cardiovascular, noncardiovascular, and unknown causes of death.
Death related to anesthesia, respiratory diseases, central nervous system diseases, hepatobiliary diseases, toxicoses, endocrine diseases, trauma.